Daily supplementation of beta-hydroxy-beta-methylbutyrate (HMB) could improve overall daily activity in Duchenne muscular dystrophy (DMD), a study found.
Chronic lymphocytic leukemia (CLL) is a mature B-cell hematological malignancy characterized by progressive clonal proliferation of B lymphocytes in the peripheral blood, bone marrow, and lymph nodes.
The study will investigate real-life prescribing practices and outcomes to identify knowledge gaps and improve drug access for patients. A new study is recruiting patients with the aim of evaluating ...
A risk model comprised of 18 mitochondria-related genes (MRGs) offers the potential to provide personalized prognostic assessment and to guide treatment for patients with diffuse large B-cell lymphoma ...
Almost half of patients were paying for additional private health insurance for their disease. The role of social determinants of health in autoimmune liver diseases such as primary biliary ...
New research indicates that obinutuzumab is a potentially effective and cost-effective treatment for patients with rituximab-resistant AAV. Obinutuzumab therapy demonstrated immunological superiority ...
91.7% of prognostic studies reported a significant association between bilirubin levels and outcomes. The levels of bilirubin and alkaline phosphatase, as well as composites including these 2, can be ...